Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe - PubMed (original) (raw)
. 2002 Feb;125(Pt 2):391-403.
doi: 10.1093/brain/awf033.
Affiliations
- PMID: 11844739
- DOI: 10.1093/brain/awf033
Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe
A J Harding et al. Brain. 2002 Feb.
Abstract
Consensus opinion characterizes dementia with Lewy bodies (DLB) as a progressive dementing illness, with significant fluctuations in cognition, visual hallucinations and/or parkinsonism. When parkinsonism is an early dominant feature, consensus opinion recommends that dementia within the first year is necessary for a diagnosis of DLB. If dementia occurs later, a diagnosis of Parkinson's disease with dementia (PDD) is recommended. While many previous studies have correlated the neuropathology in DLB with dementia and parkinsonism, few have analysed the relationship between fluctuating cognition and/or well-formed visual hallucinations and the underlying neuropathology in DLB and PDD. The aim of the present study was to determine any relationship between these less-studied core clinical features of DLB, and the distribution and density of cortical Lewy bodies (LB). The brains of 63 cases with LB were obtained over 6 years following population-based studies of dementia and parkinsonian syndromes. Annual, internationally standardized, clinical assessment batteries were reviewed to determine the presence and onset of the core clinical features of DLB. The maximal density of LB, plaques and tangles in the amygdala, parahippocampal, anterior cingulate, superior frontal, inferior temporal, inferior parietal and visual cortices were determined. Current clinicopathological diagnostic criteria were used to classify cases into DLB (n = 29), PDD (n = 18) or parkinsonism without dementia (n = 16) groups. Predictive statistics were used to ascertain whether fluctuating cognition or visual hallucinations predicted the clinicopathological group. Analysis of variance and regressions were used to identify any significant relationship(s) between the presence and severity of neuropathological and clinical features. Cognitive fluctuations and/or visual hallucinations were not good predictors of DLB in pathologically proven patients, although the absence of these features early in the disease course was highly predictive of PDD. Cases with DLB had higher LB densities in the inferior temporal cortex than cases with PDD. There was no association across groups between any neuropathological variable and the presence or absence of fluctuating cognition. However, there was a striking association between the distribution of temporal lobe LB and well-formed visual hallucinations. Cases with well-formed visual hallucinations had high densities of LB in the amygdala and parahippocampus, with early hallucinations relating to higher densities in parahippocampal and inferior temporal cortices. These temporal regions have previously been associated with visual hallucinations in other disorders. Thus, our results suggest that the distribution of temporal lobe LB is more related to the presence and duration of visual hallucinations in cases with LB than to the presence, severity or duration of dementia.
Similar articles
- Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
Jellinger KA. Jellinger KA. J Neural Transm (Vienna). 2018 Apr;125(4):615-650. doi: 10.1007/s00702-017-1821-9. Epub 2017 Dec 8. J Neural Transm (Vienna). 2018. PMID: 29222591 Review. - Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?
Jellinger KA, Korczyn AD. Jellinger KA, et al. BMC Med. 2018 Mar 6;16(1):34. doi: 10.1186/s12916-018-1016-8. BMC Med. 2018. PMID: 29510692 Free PMC article. - Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
Beyer MK, Larsen JP, Aarsland D. Beyer MK, et al. Neurology. 2007 Aug 21;69(8):747-54. doi: 10.1212/01.wnl.0000269666.62598.1c. Neurology. 2007. PMID: 17709706 - Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies.
Peavy GM, Edland SD, Toole BM, Hansen LA, Galasko DR, Mayo AM. Peavy GM, et al. Parkinsonism Relat Disord. 2016 Oct;31:72-78. doi: 10.1016/j.parkreldis.2016.07.008. Epub 2016 Jul 21. Parkinsonism Relat Disord. 2016. PMID: 27475955 Free PMC article. - [Pathological and clinical comparison of Parkinson’s disease dementia and dementia with Lewy bodies].
Bencs V, Bencze J, Módis VL, Simon V, Kálmán J, Hortobágyi T. Bencs V, et al. Orv Hetil. 2020 May 1;161(18):727-737. doi: 10.1556/650.2020.31715. Orv Hetil. 2020. PMID: 32338488 Review. Hungarian.
Cited by
- Mitochondrial quality, dynamics and functional capacity in Parkinson's disease cybrid cell lines selected for Lewy body expression.
Cronin-Furman EN, Borland MK, Bergquist KE, Bennett JP Jr, Trimmer PA. Cronin-Furman EN, et al. Mol Neurodegener. 2013 Jan 26;8:6. doi: 10.1186/1750-1326-8-6. Mol Neurodegener. 2013. PMID: 23351342 Free PMC article. - Modelling phenomenological differences in aetiologically distinct visual hallucinations using deep neural networks.
Suzuki K, Seth AK, Schwartzman DJ. Suzuki K, et al. Front Hum Neurosci. 2024 Jan 3;17:1159821. doi: 10.3389/fnhum.2023.1159821. eCollection 2023. Front Hum Neurosci. 2024. PMID: 38234594 Free PMC article. - The epidemiology of dementia associated with Parkinson's disease.
Aarsland D, Kurz MW. Aarsland D, et al. Brain Pathol. 2010 May;20(3):633-9. doi: 10.1111/j.1750-3639.2009.00369.x. Brain Pathol. 2010. PMID: 20522088 Free PMC article. Review. - Dementia with Lewy bodies.
Ferman TJ, Boeve BF. Ferman TJ, et al. Neurol Clin. 2007 Aug;25(3):741-60, vii. doi: 10.1016/j.ncl.2007.03.001. Neurol Clin. 2007. PMID: 17659188 Free PMC article. Review. - Rivastigmine in subcortical vascular dementia: a randomized, controlled, open 12-month study in 208 patients.
Moretti R, Torre P, Antonello RM, Cazzato G, Bava A. Moretti R, et al. Am J Alzheimers Dis Other Demen. 2003 Sep-Oct;18(5):265-72. doi: 10.1177/153331750301800508. Am J Alzheimers Dis Other Demen. 2003. PMID: 14569643 Free PMC article. Clinical Trial.